Yale University

Publications

Filters: Keyword is Opioid-Related Disorders  [Clear All Filters]
Journal Article
Springer, Sandra A., Jingjun Qiu, Ali Shabahang Saber-Tehrani, and Frederick L. Altice. "Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners." PloS one 7, no. 5 (2012): e38335. Abstract
McCance-Katz, Elinore F., David E. Moody, Sudha Prathikanti, Gerald Friedland, and Petrie M. Rainey. "Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients." Drug and alcohol dependence 118, no. 2-3 (2011): 326-34. Abstract
Meng, Jinmei, and Scott Burris. "The role of the Chinese police in methadone maintenance therapy: a literature review." The International journal on drug policy 24, no. 6 (2013): e25-34. Abstract
Green, Traci C., Lauretta E. Grau, Ksenia N. Blinnikova, Mikhail Torban, Evgeny Krupitsky, Ruslan Ilyuk, Andrei Kozlov, and Robert Heimer. "Social and structural aspects of the overdose risk environment in St. Petersburg, Russia." The International journal on drug policy 20, no. 3 (2009): 270-6. Abstract
Favrat, Bernard, Surita Rao, Patrick G. O'Connor, and Richard Schottenfeld. "A staging system to predict prognosis among methadone maintenance patients, based on admission characteristics." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 23, no. 4 (2002): 233-44. Abstract
Fiellin, David A.. "Substance use of disorders in HIV-infected patients: impact and new treatment strategies." Topics in HIV medicine : a publication of the International AIDS Society, USA 12, no. 3 (2004): 77-82. Abstract
Gowing, L., M. Farrell, R. Bornemann, L. Sullivan, and R. Ali. "Substitution treatment of injecting opioid users for prevention of HIV infection." Cochrane database of systematic reviews (Online), no. 2 (2008): CD004145. Abstract
Bruce, Douglas R., David E. Moody, Wenfang B. Fang, Diane Chodkowski, Laurie Andrews, and Gerald H. Friedland. "Tipranavir/ritonavir induction of buprenorphine glucuronide metabolism in HIV-negative subjects chronically receiving buprenorphine/naloxone." The American journal of drug and alcohol abuse 37, no. 4 (2011): 224-8. Abstract
Sullivan, Lynn E., Jeanette Tetrault, Deepa Bangalore, and David A. Fiellin. "Training HIV physicians to prescribe buprenorphine for opioid dependence." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 27, no. 3 (2006): 13-8. Abstract
Fiellin, David A.. "Treatment of adolescent opioid dependence: no quick fix." JAMA : the journal of the American Medical Association 300, no. 17 (2008): 2057-9.
Sullivan, Lynn E., Declan Barry, Brent A. Moore, Marek C. Chawarski, Jeanette M. Tetrault, Michael V. Pantalon, Patrick G. O'Connor, Richard S. Schottenfeld, and David A. Fiellin. "A trial of integrated buprenorphine/naloxone and HIV clinical care." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S184-90. Abstract
Vivian, James, Hassan Saleheen, Merrill Singer, Juhem Navarro, and Greg Mirhej. "Under the counter: the diffusion of narcotic analgesics to the inner city street." Journal of ethnicity in substance abuse 4, no. 2 (2005): 97-114. Abstract
Gunderson, Erik W., Xin-Qun Wang, David A. Fiellin, Benjamin Bryan, and Frances R. Levin. "Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial." Addictive behaviors 35, no. 5 (2010): 537-40. Abstract
Gordon, Adam J., Lynn E. Sullivan, Daniel P. Alford, Julia H. Arnsten, Marc N. Gourevitch, Stefan G. Kertesz, Hillary V. Kunins, Joseph O. Merrill, Jeffrey H. Samet, and David A. Fiellin. "Update in addiction medicine for the generalist." Journal of general internal medicine 22, no. 8 (2007): 1190-4.
Barry, Declan T., Jonathan D. Savant, Mark Beitel, Christopher J. Cutter, Brent A. Moore, Richard S. Schottenfeld, and David A. Fiellin. "Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone." Journal of addiction medicine 6, no. 4 (2012): 274-9. Abstract
Feingold, Alan, Alison Oliveto, Richard Schottenfeld, and Thomas R. Kosten. "Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 11, no. 2 (2002): 111-23. Abstract
Chawarski, Marek C., David A. Fiellin, Patrick G. O'Connor, Mathew Bernard, and Richard S. Schottenfeld. "Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence." Journal of substance abuse treatment 33, no. 4 (2007): 411-5. Abstract
Culbert, Gabriel J., Agung Waluyo, Mariska Iriyanti, Azalia P. Muchransyah, Adeeba Kamarulzaman, and Frederick L. Altice. "Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice." Drug and alcohol dependence 149 (2015): 71-9. Abstract
Jones, Emlyn S., and David A. Fiellin. "Women and opioid dependence treatment: office-based versus opioid treatment program-based care?" Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 28, no. 2 (2007): 3-8. Abstract